Assistant Professor of Medicine

E-Mail

Hospital of The University of Pennsylvania
Department of Medicine
Cardiovascular Medicine Division
9.047 West Gatest Pavilion
3400 Spruce Street
Philadelphia, PA 19104-4283

Appointments
Contact: Denise Bray (215) 615-4333

Clinical Specialty:

• Cardiovascular Medicine
• Interventional Cardiology

Practice Location:

• Hospital of The University of Pennsylvania, Founders Pavilion
• Penn Cardiac Care at Radnor

Education:

• MD: Cornell University Medical College, New York, NY
• Residency: Hosptial of the University of Pennsylvania, Philadelphia, PA
• Fellowship: Hospital of the University of Pennsylvania, Philadelphia, PA
• Interventional: Hospital of the University of Pennsylvania, Philadelphia, PA
• Master Clinical Epidemiology: University of Pennsylvania School of Medicine, Philadelphia, PA

Research Interest:

• Cardiac Catheterization
• Angioplasty and Stents
• Myocardial Infarction
• Catheter Closure of Patent Foramen Ovale and Atrial Septal Defects
• Women with Coronary Artery Disease
• High Risk Angioplasty
• Peripheral Vascular Disease and Catheter Intervention

Selected Publications:

1. Glaser, R., Lu, M., Narula, N., and Epstein, J.A. Smooth Muscle Cells, But Not Myocytes, of Host Origin in Transplanted Human Hearts.  Circulation . 2002; 106: 17-19.
2. Glaser, R., Herrmann, H.C., Murphy, S.A., Demopoulos, L.A., DiBattiste, P.M., Cannon, C.P., Braunwald, E.  Benefit of an Early Invasive Management Strategy in Women with Acute Coronary Syndromes.  JAMA.  2002; 288: 3124-3128
3. Glaser, R., Selzer, F., Faxon, D., Laskey, WK, Detre, KM, Wilensky, RL.   Risk of Major Adverse Cardiac Events from Incidental Asymptomatic Lesions Following Culprit Vessel Coronary Intervention: Observations from the NHLBI Dynamic Registry.  Circulation.  2005; 111: 143-149.
4. Herrmann, HC, Silvestry, F.E., Glaser, R., See, V., Kasner, S., Bradbury, D., Chang, G., Hirshfeld, J.W., Horwitz, P.A., Kelly, M. Percutaneous Patent Foramen Ovale and Atrial Defect Closure in Adults: Results and Device in 100 Consecutive Implants at a Single Center. Catheterization and Cardiovascular Interventions. 2005; 64:197–203.
5. Naidu, SS, Wilensky, RL, Selzer, F, Laskey WK, Srinivas VS, Slater, JN, Glaser, R. Off-Hour Primary Angioplasty: Why Is Mortality Higher?  (Abstract) J Am Coll Cardiol Suppl.  2005; 
6. Trost, J, Glaser, R.  Treatment of Saphenous Vein Graft Lesions with Drug Eluting Stents: A Report from the National Heart, Lung, and Blood Institute Dynamic Registry.  (Abstract) Circulation.  2005;
7. Kolansky, DK, Shah, AJ, Mannion, T, Glaser, R, Hirshfeld, Jr., JH, Wilensky, RL, Herrmann, HC.  Filterwire™Distal Embolic Protection Device for Vein Graft Stenting: Initial Single-Center Experience. Clin. Cardiol. 2005; 28: 556–560.
8. Berkowitz, JM Glaser, R, Wilensky, RL, Selzer, F, King, SB Srinivas, VS Qureshi, E, Slater, J. Use of Various Anti-coagulation strategies in the National Heart, Lung, and Blood Institute Dynamic Registry : Patient Profiles and Complications. (Abstract) Circulation. 2005;
9. Glaser, R, Glick, HA, Herrmann, HC, Kimmel, SE.  The Role of Risk Stratification in the Decision to Provide Upstream Versus Selective Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes: A Cost-Effectiveness Analysis. Journal of the American College of Cardiology. 2006; 47: 529-37.
10. Glaser R, Glick HA, Herrmann HC, Kimmel SE. Cost-Effectiveness of Upstream Versus Selective Glycoprotein IIb/IIIa Inhibitors for Acute Coronary Syndromes Reply.  Journal of the American College of Cardiology. 2007; 49(2):277. Epub 2006 Dec 29.
11. Glaser R, Selzer F, Jacobs AK, Laskey WK, Kelsey SF, Holper EM, Cohen HA, Abbott JD, Wilensky RL. Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes.  Am J Cardiol. 2006; 98(11):1446-50. Epub 2006 Oct 13.
12. Abbott JD, Vlachos HA, Selzer F, Sharaf BL, Holper E, Glaser R, Jacobs AK, Williams DO. Gender-Based Outcomes in Percutaneous Coronary Intervention With Drug-Eluting Stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2007 Mar 1;99(5):626-31. Epub 2007 Jan 9. 
13. Glaser, R., Herrmann, H.C.  Early, Rescue and Facilitated Percutaneous Coronary Intervention for Acute Myocardial Infarction. ACC Current Journal Review. 2001; 10: 62-66. 
14. Glaser, R., Herrmann, H.C. Does Primary Stent Implantation Increase Late Mortality after Myocardial Infarction?  Catheterization and Cardiovascular Interventions. 2001; 54: 333-4.
15. Glaser, R., Wiegers S.E.  Evaluation of Diabetic Patients for Cardiac and Peripheral Vascular Disease.  Chapter 30 in Textbook of Type 2 Diabetes, ed. Goldstein and Muller-Wieland, London, United Kingdom: Martin Dunitz Ltd, 2002.
16. Glaser, R., Kolansky, D.  Hemodynamic Assessment in the Cardiac Catheterization Laboratory.  Chapter in Textbook of Congestive Heart Failure, ed. Loh and Jessup, Totowa, New Jersey: Humana Press, 2003.
17. Glaser, R., Herrmann, H. C. Benefits of early invasive strategy for unstable coronary artery disease remain after 2 years.  Evidence-based Cardiovascular Medicine.  2003; 7
18. Naidu, SS, Rohatgi, R., Herrmann, HC, Glaser, R. Unprotected Left Main “Kissing” Stent Implantation With a Percutaneous Ventricular Assist Device.  Journal of Invasive Cardiology.  2004; 16(11):683-684 .
19. Glaser, R., Herrmann, H.C. Safety of Vascular Closure Devices—Are Women Different? Journal of Invasive Cardiology.  2004; 16(9):464-465.
20. Glaser, R., Herrmann, H.C. Percutaneous Coronary Intervention in African-Americans-Closing the ‘Gender Gap’ Journal of Invasive Cardiology.  2007; 19(3):129-130.